Clinical trial
Gemcitabine, Ascorbate, Radiation Therapy for Pancreatic Cancer, Phase I
NCT01852890 is registered in ClinicalTrials.gov with Joseph J. Cullen as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Gemcitabine, Ascorbate, Radiation Therapy for Pancreatic Cancer, Phase I
- Lead sponsor
- Joseph J. Cullen
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- January 31, 2014
- Completion date
- October 14, 2025
- Enrollment
- 16 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.